SCHEMBL25979151

SCHEMBL25979151

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3ccc(-c5ccc(N(c6ccccc6)c6ccc(-n7c8ccccc8c8ccccc87)cc6)cc5)cc34)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
CHEK2 O96017 1/20 0.32
MMP12 P39900 2/20 0.32
MMP13 P45452 1/20 0.32
TSPO P30536 1/20 0.31
HDAC4 P56524 1/20 0.31
PGR P06401 1/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
PTGER4 P35408 2/20 0.31
GAA P10253 1/20 0.30
HCRTR1 O43613 1/20 0.30
TBK1 Q9UHD2 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979452 0.96 KDM4E (0.34) L3MBTL1ATMKDM4ECHEK2MMP12
SCHEMBL25979737 0.96 KDM4E (0.37) L3MBTL1ATMKDM4EMMP12MMP13
SCHEMBL26779070 0.95 KDM4E (0.35) L3MBTL1ATMKDM4ECHEK2MMP12
SCHEMBL25979972 0.93 KDM4E (0.36) L3MBTL1ATMKDM4EHDAC4PTGER4
SCHEMBL26779217 0.92 KDM4E (0.37) L3MBTL1ATMKDM4EHDAC4PTGER4
SCHEMBL23913446 0.92 PLA2G2A (0.39) L3MBTL1ATMKDM4EPLA2G2APLA2G4A
SCHEMBL25978860 0.91 KDM4E (0.36) L3MBTL1ATMKDM4ECHEK2SIRT2
SCHEMBL25978858 0.91 KDM4E (0.36) L3MBTL1ATMKDM4ECHEK2SIRT2
SCHEMBL16261031 0.91 KDM4E (0.38) L3MBTL1ATMKDM4EPLA2G2APLA2G4A
SCHEMBL15785811 0.91 TSPO (0.36) L3MBTL1ATMKDM4EPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 L3MBTL1 1367/4885ATM 3135/4885KDM4E 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.